ArticleCase reports in hematology2017

Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemotherapy: Report of a Case.

Cristina Bucelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.